Does Weight Impact Anidulafungin Pharmacokinetics?

Drug Disposition in Obesity: Toward Evidence-Based Dosing

(2015) Catherijne A.J. Knibbe et al.   Annual Review of Pharmacology and Toxicology

Population Pharmacokinetic Analysis of Voriconazole and Anidulafungin in Adult Patients with Invasive Aspergillosis

(2014) Ping Liu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Weight Drives Caspofungin Pharmacokinetic Variability in Overweight and Obese People: Fractal Power Signatures beyond Two-Thirds or Three-Fourths

(2013) Ronald G. Hall et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacokinetics of Anidulafungin in Critically Ill Patients with Candidemia/Invasive Candidiasis

(2013) Ping Liu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Population Pharmacokinetic-Pharmacodynamic Analysis of Anidulafungin in Adult Patients with Fungal Infections

(2012) Ping Liu   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Fractal Geometry and the Pharmacometrics of Micafungin in Overweight, Obese, and Extremely Obese People

(2011) Ronald G. Hall et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Global burden of obesity in 2005 and projections to 2030

(2008) T Kelly et al.   INTERNATIONAL JOURNAL OF OBESITY